(Q44444695)

3 December 2017

title

Migraine prevalence during menopausal transition (English)

1 reference

3 December 2017

1 reference

2

1 reference

3 December 2017

1

Shuu-Jiun Wang

1 reference

3 December 2017

5

Peng-Hui Wang

1 reference

3 December 2017

4

Kai-Dih Juang

1 reference

3 December 2017

Shiang-Ru Lu

3

1 reference

3 December 2017

publication date

1 May 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

43

1 reference

3 December 2017

issue

5

1 reference

3 December 2017

page(s)

470-478

1 reference

Migraine and reporoductive hormones throughout the menstrual cycle

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03092.X

Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03092.X

Estrogens, progestins, and headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03092.X

Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03092.X

Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03092.X

The Kinmen women-health investigation (KIWI): a menopausal study of a population aged 40-54.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03092.X

Perimenstrual symptoms: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03092.X

Luteal phase ovarian steroids, stress arousal, premenses perceived stress, and premenstrual symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03092.X

The confirmation of a biochemical marker for women's hormonal migraine: the depo-estradiol challenge test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03092.X

Course of primary headaches during hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03092.X

10.1046/J.1526-4610.2003.03092.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference